Cargando…
Serum levels of interleukin 33 and its receptor ST2 in patients treated with subcutaneous allergen immunotherapy in intermittent allergic rhinitis
INTRODUCTION: Interleukin 33 (IL-33) is a pleiotropic cytokine involved in pathological processes in seasonal allergic rhinitis. IL-33 binds to ST2 receptor, which is highly expressed on mast cells and selectively on Th2 cells. Information is lacking on the role of IL-33/ST2 axis in allergen subcuta...
Autores principales: | Glück, Joanna, Rymarczyk, Barbara, Jura-Szołtys, Edyta, Rogala, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745539/ https://www.ncbi.nlm.nih.gov/pubmed/31530993 http://dx.doi.org/10.5114/ceji.2019.87075 |
Ejemplares similares
-
Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2022) -
Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
por: Glück, Joanna, et al.
Publicado: (2012) -
The Role of Interleukin-33 in Rhinitis
por: Rogala, Barbara, et al.
Publicado: (2013) -
Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018) -
Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)